日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Tumor metabolic adaptation induced by L-asparaginase reveals a vulnerability to PARP1/2 inhibitor in B-cell lymphomas.

L-天冬酰胺酶诱导的肿瘤代谢适应揭示了B细胞淋巴瘤对PARP1/2抑制剂的脆弱性。

Aussel Anaïs, Nemazanyy Ivan, Vandenberghe Ashaina, Meola Pauline, Dorat Noémie, Paul Rachel, Habbouche Lama, Exposito Laurie, Nottet Nicolas, Petrilli Virginie, Chiche Edmond, Mounier Nicolas, Marchetti Sandrine, Chaveroux Cédric, Ricci Jean-Ehrland, Chiche Johanna

Adapted physical activity for hematology inpatients: focus on lean mass gain

针对血液科住院患者的适应性体育活动:重点在于增加瘦体重

Sudria, Axel; Loschi, Michael; Pinto, Andrea; Crousse, Laura; Benachour, Sami; Sammut, Rinzine; Chorin, Frederic; Mounier, Nicolas; Cluzeau, Thomas

Brentuximab vedotin with AVD for stage II-IV HIV-related Hodgkin lymphoma (AMC 085): phase 2 results from an open-label, single arm, multicentre phase 1/2 trial

Brentuximab vedotin联合AVD治疗II-IV期HIV相关霍奇金淋巴瘤(AMC 085):一项开放标签、单臂、多中心1/2期试验的2期结果

Rubinstein, Paul G; Moore, Page C; Bimali, Milan; Lee, Jeanette Y; Rudek, Michelle A; Chadburn, Amy; Ratner, Lee; Henry, David H; Cesarman, Ethel; DeMarco, Camille E; Costagliola, Dominique; Taoufik, Yassine; Ramos, Juan Carlos; Sharon, Elad; Reid, Erin G; Ambinder, Richard F; Mitsuyasu, Ronald; Mounier, Nicolas; Besson, Caroline; Noy, Ariela

Quality of life of survivors 1 year after the diagnosis of diffuse large B-cell lymphoma: a LYSA study

弥漫性大B细胞淋巴瘤确诊1年后幸存者的生活质量:一项LYSA研究

Paunescu, Alexandra-Cristina; Copie, Christiane Bergman; Malak, Sandra; Gouill, Steven Le; Ribrag, Vincent; Bouabdallah, Krimo; Sibon, David; Rumpold, Gerhard; Preau, Marie; Mounier, Nicolas; Haioun, Corinne; Jardin, Fabrice; Besson, Caroline

Correction to: Quality of life of survivors 1 year after the diagnosis of diffuse large B-cell lymphoma: a LYSA study

更正:弥漫性大B细胞淋巴瘤诊断一年后幸存者的生活质量:一项LYSA研究

Paunescu, Alexandra-Cristina; Copie Bergman, Christiane; Malak, Sandra; Le Gouill, Steven; Ribrag, Vincent; Bouabdallah, Krimo; Sibon, David; Rumpold, Gerhard; Preau, Marie; Mounier, Nicolas; Haioun, Corinne; Jardin, Fabrice; Besson, Caroline

Lenalidomide maintenance for diffuse large B-cell lymphoma patients responding to R-CHOP: quality of life, dosing, and safety results from the randomised controlled REMARC study

来那度胺维持治疗对 R-CHOP 方案有反应的弥漫性大 B 细胞淋巴瘤患者:来自随机对照 REMARC 研究的生活质量、剂量和安全性结果

Thieblemont, Catherine; Howlett, Susannah; Casasnovas, René-Olivier; Mounier, Nicolas; Perrot, Aurore; Morschhauser, Franck; Fruchart, Christophe; Daguindau, Nicolas; van Eygen, Koen; Obéric, Lucie; Bouabdallah, Reda; Pica, Gian Matteo; Nicolas-Virezelier, Emmanuelle; Abraham, Julie; Fitoussi, Olivier; Snauwaert, Sylvia; Eisenmann, Jean-Claude; Lionne-Huyghe, Pauline; Bron, Dominique; Tricot, Sabine; Deeren, Dries; Gonzalez, Hugo; Costello, Régis; Le Du, Katell; da Silva, Maria Gomes; Grosicki, Sebastian; Trotman, Judith; Catalano, John; Caballero, Dolores; Greil, Richard; Cohen, Amos M; Gaulard, Philippe; Roulin, Louise; Takeshita, Kenichi; Casadebaig, Marie-Laure; Tilly, Hervé; Coiffier, Bertrand

Long-term overall survival and toxicities of ABVD vs BEACOPP in advanced Hodgkin lymphoma: A pooled analysis of four randomized trials

ABVD方案与BEACOPP方案治疗晚期霍奇金淋巴瘤的长期总生存率和毒性:四项随机试验的汇总分析

André, Marc P E; Carde, Patrice; Viviani, Simonetta; Bellei, Monica; Fortpied, Catherine; Hutchings, Martin; Gianni, Alessandro M; Brice, Pauline; Casasnovas, Olivier; Gobbi, Paolo G; Zinzani, Pier Luigi; Dupuis, Jehan; Iannitto, Emilio; Rambaldi, Alessandro; Brière, Josette; Clément-Filliatre, Laurianne; Heczko, Marian; Valagussa, Pinuccia; Douxfils, Jonathan; Depaus, Julien; Federico, Massimo; Mounier, Nicolas

Fatigue level changes with time in long-term Hodgkin and non-Hodgkin lymphoma survivors: a joint EORTC-LYSA cross-sectional study

霍奇金淋巴瘤和非霍奇金淋巴瘤长期幸存者疲劳程度随时间的变化:一项EORTC-LYSA联合横断面研究

Busson, Raphaël; van der Kaaij, Marleen; Mounier, Nicolas; Aleman, Berthe M P; Thiéblemont, Catherine; Stamatoullas, Aspasia; Ribrag, Vincent; Tilly, Hervé; Haioun, Corinne; Casasnovas, René-Olivier; Kluin-Nelemans, Hanneke C; Henry-Amar, Michel

Central nervous system relapse in patients over 80 years with diffuse large B-cell lymphoma: an analysis of two LYSA studies

弥漫性大B细胞淋巴瘤患者中枢神经系统复发:两项LYSA研究的分析(患者年龄超过80岁)

Cabannes-Hamy, Aurélie; Peyrade, Frederic; Jardin, Fabrice; Emile, Jean-François; Delwail, Vincent; Mounier, Nicolas; Haioun, Corinne; Perrot, Aurore; Fitoussi, Olivier; Lara, Diane; Delarue, Richard; André, Marc; Offner, Fritz; Ghesquières, Hervé; Pascal, Laurent; Soussain, Carole; Lazarovici, Julien; Schiano, Jean-Marc; Gaulard, Philippe; Tilly, Hervé; Thieblemont, Catherine

VEGF(121), is predictor for survival in activated B-cell-like diffuse large B-cell lymphoma and is related to an immune response gene signature conserved in cancers.

VEGF(121) 是活化 B 细胞样弥漫性大 B 细胞淋巴瘤生存的预测因子,并且与癌症中保守的免疫反应基因特征相关。

Broséus Julien, Mourah Samia, Ramstein Gérard, Bernard Sophie, Mounier Nicolas, Cuccuini Wendy, Gaulard Philippe, Gisselbrecht Christian, Brière Josette, Houlgatte Rémi, Thieblemont Catherine